Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Similar articles for PubMed (Select 22983013)


Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques.

Lorin C, Segal L, Mols J, Morelle D, Bourguignon P, Rovira O, Mettens P, Silvano J, Dumey N, Le Goff F, Koutsoukos M, Voss G, Tangy F.

Naunyn Schmiedebergs Arch Pharmacol. 2012 Dec;385(12):1211-25. doi: 10.1007/s00210-012-0793-4. Epub 2012 Sep 16.


Immunogenicity of a recombinant measles-HIV-1 clade B candidate vaccine.

Stebbings R, Février M, Li B, Lorin C, Koutsoukos M, Mee E, Rose N, Hall J, Page M, Almond N, Voss G, Tangy F.

PLoS One. 2012;7(11):e50397. doi: 10.1371/journal.pone.0050397. Epub 2012 Nov 30.


A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice.

Combredet C, Labrousse V, Mollet L, Lorin C, Delebecque F, Hurtrel B, McClure H, Feinberg MB, Brahic M, Tangy F.

J Virol. 2003 Nov;77(21):11546-54.


Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses.

Liniger M, Zuniga A, Morin TN, Combardiere B, Marty R, Wiegand M, Ilter O, Knuchel M, Naim HY.

Vaccine. 2009 May 26;27(25-26):3299-305. doi: 10.1016/j.vaccine.2009.01.057. Epub 2009 Feb 5.


Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates.

Rennick LJ, de Vries RD, Carsillo TJ, Lemon K, van Amerongen G, Ludlow M, Nguyen DT, Yüksel S, Verburgh RJ, Haddock P, McQuaid S, Duprex WP, de Swart RL.

J Virol. 2015 Feb;89(4):2192-200. doi: 10.1128/JVI.02924-14. Epub 2014 Dec 3.


Biodistribution and toxicological safety of adenovirus type 5 and type 35 vectored vaccines against human immunodeficiency virus-1 (HIV-1), Ebola, or Marburg are similar despite differing adenovirus serotype vector, manufacturer's construct, or gene inserts.

Sheets RL, Stein J, Bailer RT, Koup RA, Andrews C, Nason M, He B, Koo E, Trotter H, Duffy C, Manetz TS, Gomez P.

J Immunotoxicol. 2008 Jul;5(3):315-35. doi: 10.1080/15376510802312464.


A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles.

Pan CH, Greer CE, Hauer D, Legg HS, Lee EY, Bergen MJ, Lau B, Adams RJ, Polo JM, Griffin DE.

J Virol. 2010 Apr;84(8):3798-807. doi: 10.1128/JVI.01566-09. Epub 2010 Feb 3.


Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines.

Brandler S, Tangy F.

Comp Immunol Microbiol Infect Dis. 2008 Mar;31(2-3):271-91. Epub 2007 Sep 14.


Immunogenicity of a recombinant measles HIV-1 subtype C vaccine.

Stebbings R, Li B, Lorin C, Koutsoukos M, Février M, Mee ET, Page M, Almond N, Tangy F, Voss G.

Vaccine. 2013 Dec 9;31(51):6079-86. doi: 10.1016/j.vaccine.2013.09.072. Epub 2013 Oct 24.


Live attenuated measles vaccine as a potential multivalent pediatric vaccination vector.

Tangy F, Naim HY.

Viral Immunol. 2005;18(2):317-26. Review.


Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic.

Guerbois M, Moris A, Combredet C, Najburg V, Ruffié C, Février M, Cayet N, Brandler S, Schwartz O, Tangy F.

Virology. 2009 May 25;388(1):191-203. doi: 10.1016/j.virol.2009.02.047. Epub 2009 Apr 5.


Wild-type measles virus with the hemagglutinin protein of the edmonston vaccine strain retains wild-type tropism in macaques.

Takeuchi K, Nagata N, Kato SI, Ami Y, Suzaki Y, Suzuki T, Sato Y, Tsunetsugu-Yokota Y, Mori K, Van Nguyen N, Kimura H, Nagata K.

J Virol. 2012 Mar;86(6):3027-37. doi: 10.1128/JVI.06517-11. Epub 2012 Jan 11.


Comparative efficacy of a canine distemper-measles and a standard measles vaccine for immunization of rhesus macaques (Macaca mulatta).

Christe KL, McChesney MB, Spinner A, Rosenthal AN, Allen PC, Valverde CR, Roberts JA, Lerche NW.

Comp Med. 2002 Oct;52(5):467-72.


Infection of cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta) with different wild-type measles viruses.

El Mubarak HS, Yüksel S, van Amerongen G, Mulder PG, Mukhtar MM, Osterhaus AD, de Swart RL.

J Gen Virol. 2007 Jul;88(Pt 7):2028-34.


Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies.

van Binnendijk RS, Poelen MC, van Amerongen G, de Vries P, Osterhaus AD.

J Infect Dis. 1997 Mar;175(3):524-32.


Enteric administration of a live attenuated measles vaccine does not induce protective immunity in a macaque model.

Stittelaar KJ, de Swart RL, Vos HW, van Amerongen G, Agafonov AP, Nechaeva EA, Osterhaus AD.

Vaccine. 2002 Jul 26;20(23-24):2906-12.


Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.

Song MK, Vindurampulle CJ, Capozzo AV, Ulmer J, Polo JM, Pasetti MF, Barry EM, Levine MM.

J Virol. 2005 Aug;79(15):9854-61.


Measles in the cynomolgus monkey (Macaca fascicularis).

Welshman MD.

Vet Rec. 1989 Feb 25;124(8):184-6.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk